Morepen files first US drug application, eyes generic diabetes market

Morepen Laboratories Ltd submitted its first Abbreviated New Drug Application (ANDA) to the US Food and Drug Administration on September 25, 2026, for Sitagliptin Tablets USP in three dosage strengths, 25 mg, 50 mg, and 100 mg. The filing marks the Indian pharmaceutical company’s entry into finishe…